Literature DB >> 18601962

Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes.

Debra T Auguste1, Kay Furman, Andrew Wong, Jason Fuller, Steven P Armes, Timothy J Deming, Robert Langer.   

Abstract

The ability of small interfering RNA (siRNA) to regulate gene expression has potential therapeutic applications, but its use is limited by inefficient delivery. Triggered release of adsorbed poly(ethylene glycol) (PEG)-b-polycation polymers from pH-dependent (PD) liposomes enables protection from immune recognition during circulation (pH 7.4) and subsequent intracellular delivery of siRNA within the endosome (pH ~5.5). Polycationic blocks, based on either poly[2-(dimethylamino)ethyl methacrylate] (31 or 62 DMA repeat units) or polylysine (21 K repeat units), act as anchors for a PEG (113 ethylene glycol repeat units) protective block. Incorporation of 1,2-dioleoyl-3-dimethylammonium-propane (DAP), a titratable lipid, increases the liposome's net cationic character within acidic environments, resulting in polymer desorption and membrane fusion. Liposomes encapsulating siRNA demonstrate green fluorescent protein (GFP) silencing in genetically-modified, GFP-expressing HeLa cells and glyceraldehyde-3-phosphate dehydrogenase (GAPD) knockdown in human umbilical vein endothelial cells (HUVEC). Bare and PD liposomes coated with PEG113-DMA31 exhibit a 0.16+/-0.2 and 0.32+/-0.3 fraction of GFP knockdown, respectively. In contrast, direct siRNA administration and Oligofectamine complexed siRNA reduce GFP expression by 0.06+/-0.02 and 0.14+/-0.02 fractions, respectively. Our in vitro data indicates that polymer desorption from PD liposomes enhances siRNA-mediated gene knockdown.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18601962      PMCID: PMC2608725          DOI: 10.1016/j.jconrel.2008.06.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  32 in total

Review 1.  Novel applications of liposomes.

Authors:  D D Lasic
Journal:  Trends Biotechnol       Date:  1998-07       Impact factor: 19.536

2.  RNA quantitation by fluorescence-based solution assay: RiboGreen reagent characterization.

Authors:  L J Jones; S T Yue; C Y Cheung; V L Singer
Journal:  Anal Biochem       Date:  1998-12-15       Impact factor: 3.365

3.  Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia.

Authors:  Pedro Gonzalez-Alegre; Nicole Bode; Beverly L Davidson; Henry L Paulson
Journal:  J Neurosci       Date:  2005-11-09       Impact factor: 6.167

4.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

5.  STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells.

Authors:  Mingsheng Zhang; Yunfeng Zhou; Conghua Xie; Fuxiang Zhou; Yun Chen; Guang Han; Wen Jie Zhang
Journal:  Cancer Lett       Date:  2006-01-04       Impact factor: 8.679

6.  Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.

Authors:  Sebastien Spagnou; Andrew D Miller; Michael Keller
Journal:  Biochemistry       Date:  2004-10-26       Impact factor: 3.162

7.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.

Authors:  Douglas A Rubinson; Christopher P Dillon; Adam V Kwiatkowski; Claudia Sievers; Lili Yang; Johnny Kopinja; Dina L Rooney; Mingdi Zhang; Melanie M Ihrig; Michael T McManus; Frank B Gertler; Martin L Scott; Luk Van Parijs
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

8.  Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes.

Authors:  A Chonn; S C Semple; P R Cullis
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

9.  RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis.

Authors:  Riccardo Taulli; Paolo Accornero; Antonia Follenzi; Tony Mangano; Alessandro Morotti; Claudio Scuoppo; Paolo E Forni; Francesca Bersani; Tiziana Crepaldi; Roberto Chiarle; Luigi Naldini; Carola Ponzetto
Journal:  Cancer Gene Ther       Date:  2005-05       Impact factor: 5.987

10.  siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene.

Authors:  Chunling Zhang; Ning Tang; XingJun Liu; Wei Liang; Wei Xu; Vladimir P Torchilin
Journal:  J Control Release       Date:  2006-03-20       Impact factor: 9.776

View more
  22 in total

1.  Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.

Authors:  Chao Liang; Baosheng Guo; Heng Wu; Ningsheng Shao; Defang Li; Jin Liu; Lei Dang; Cheng Wang; Hui Li; Shaohua Li; Wing Ki Lau; Yu Cao; Zhijun Yang; Cheng Lu; Xiaojuan He; D W T Au; Xiaohua Pan; Bao-Ting Zhang; Changwei Lu; Hongqi Zhang; Kinman Yue; Airong Qian; Peng Shang; Jiake Xu; Lianbo Xiao; Zhaoxiang Bian; Weihong Tan; Zicai Liang; Fuchu He; Lingqiang Zhang; Aiping Lu; Ge Zhang
Journal:  Nat Med       Date:  2015-02-09       Impact factor: 53.440

Review 2.  Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy.

Authors:  Yunching Chen; Leaf Huang
Journal:  Expert Opin Drug Deliv       Date:  2008-12       Impact factor: 6.648

Review 3.  Stimuli-responsive nanocarriers for drug delivery.

Authors:  Simona Mura; Julien Nicolas; Patrick Couvreur
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

Review 4.  siRNA Delivery by Stimuli-Sensitive Nanocarriers.

Authors:  Giuseppina Salzano; Daniel F Costa; Vladimir P Torchilin
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  Cationic lipid nanodisks as an siRNA delivery vehicle.

Authors:  Mistuni Ghosh; Gang Ren; Jens B Simonsen; Robert O Ryan
Journal:  Biochem Cell Biol       Date:  2014-04-22       Impact factor: 3.626

6.  Acid-degradable polymer-caged lipoplex (PCL) platform for siRNA delivery: facile cellular triggered release of siRNA.

Authors:  Bong Jin Hong; Anthony J Chipre; SonBinh T Nguyen
Journal:  J Am Chem Soc       Date:  2013-11-13       Impact factor: 15.419

7.  Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.

Authors:  Kaylin M McMahon; R Kannan Mutharasan; Sushant Tripathy; Dorina Veliceasa; Mariana Bobeica; Dale K Shumaker; Andrea J Luthi; Brian T Helfand; Hossein Ardehali; Chad A Mirkin; Olga Volpert; C Shad Thaxton
Journal:  Nano Lett       Date:  2011-02-14       Impact factor: 11.189

8.  Catch and Release: Photocleavable Cationic Diblock Copolymers as a Potential Platform for Nucleic Acid Delivery.

Authors:  Matthew D Green; Abbygail A Foster; Chad T Greco; Raghunath Roy; Rachel M Lehr; Thomas H Epps; Millicent O Sullivan
Journal:  Polym Chem       Date:  2014-06       Impact factor: 5.582

9.  Multi-stimuli sensitive amphiphilic block copolymer assemblies.

Authors:  Akamol Klaikherd; Chikkannagari Nagamani; S Thayumanavan
Journal:  J Am Chem Soc       Date:  2009-04-08       Impact factor: 15.419

Review 10.  Strategies on the nuclear-targeted delivery of genes.

Authors:  Jing Yao; Ying Fan; Yuanke Li; Leaf Huang
Journal:  J Drug Target       Date:  2013-08-22       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.